Predictive assays: Will they ever have a role in the clinic?

被引:23
作者
Peters, L [1 ]
McKay, M [1 ]
机构
[1] Peter MacCallum Canc Inst, Melbourne, Vic 3002, Australia
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2001年 / 49卷 / 02期
关键词
D O I
10.1016/S0360-3016(00)01469-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:501 / 504
页数:4
相关论文
共 20 条
[11]  
Hockel M, 1996, CANCER RES, V56, P4509
[12]   Measurement of tumor oxygenation [J].
Horsman, MR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (04) :701-704
[13]  
LEONG T, 2000, IN PRESS INT J RAD O
[14]   The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability [J].
Mackay, RI ;
Hendry, JH .
RADIOTHERAPY AND ONCOLOGY, 1999, 50 (01) :67-75
[15]   Coactivation of AP-1 activity and TGF-beta 1 gene expression in the stress response of normal skin cells to ionizing radiation [J].
Martin, M ;
Vozenin, MC ;
Gault, N ;
Crechet, F ;
Pfarr, CM ;
Lefaix, JL .
ONCOGENE, 1997, 15 (08) :981-989
[16]   INHERENT RADIOSENSITIVITY OF TUMOR AND NORMAL TISSUE-CELLS AS A PREDICTOR OF HUMAN TUMOR RESPONSE [J].
PETERS, LJ .
RADIOTHERAPY AND ONCOLOGY, 1990, 17 (03) :177-190
[17]   Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients [J].
Ramsay, J ;
Birrell, G ;
Lavin, M .
RADIOTHERAPY AND ONCOLOGY, 1998, 47 (02) :125-128
[18]  
Sgroi DC, 1999, CANCER RES, V59, P5656
[19]   Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients [J].
Shayeghl, M ;
Seal, S ;
Regan, J ;
Collins, N ;
Barfoot, R ;
Rahman, N ;
Ashton, A ;
Moohan, M ;
Wooster, R ;
Owen, R ;
Bliss, JM ;
Stratton, MR ;
Yarnold, J .
BRITISH JOURNAL OF CANCER, 1998, 78 (07) :922-927
[20]   INTRINSIC RADIOSENSITIVITY AS A PREDICTOR OF PATIENT RESPONSE TO RADIOTHERAPY [J].
WEST, CML .
BRITISH JOURNAL OF RADIOLOGY, 1995, 68 (812) :827-837